Hyperprogressive disease rarely occurs during checkpoint inhibitor treatment for advanced melanoma.

M SchuivelingE H J TonkR J VerheijdenKarlijn P M Suijkerbuijk

Published in: Cancer immunology, immunotherapy : CII (2020)

Hyperprogression is rare in melanoma patients treated with immune checkpoint inhibitors. Our data question if hyperprogression really is a biological entity in metastatic melanoma.

Keyphrases

dna damage
skin cancer
electronic health record
big data
basal cell carcinoma
cell proliferation
machine learning
deep learning
data analysis
artificial intelligence